glp 1 and liver disease GLP-1 Your Liver: What to Monitor While on Semaglutide or Tirzepatide Frontiers | The mechanisms of

We can see very clearly that this is specific to medications that are working through GLP-1 receptor pharmacology. In two other clinical trials, funded by pharmaceutical companies, which were not included in the meta-analysis due to methodological differences, the drug responses were similar between carriers and non-carriers

Back Finkelstein, EA, Trogdon, JG, Cohen, JW (2009) 'Annual medical spending attributable to obesity: payer-and service-specific estimates', Health Affairs , 28/5, w82231

Clinical studies showed an improvement in glycemic parameters and a substantial and dose-dependent loss of body weight

Barker LA, Bakkum BW, Chapman C